EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules

Rhoda Tano-Menka, Nishant K Singh, Itai Muzhingi, Xiaolong Li, Michael V Mandanas, Clarety Kaseke, Charles R Crain, Angela Zhang, Funsho J Ogunshola, Liza Vecchiarello, Alicja Piechocka-Trocha, Arman Bashirova und 4 weitere

Structure · 2024

DOI: 10.1016/j.str.2024.04.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2024. Verfasst von Rhoda Tano-Menka und 15 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: HLA-B Antigens, Protein Binding, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-B AntigensProtein BindingReceptors, Antigen, T-CellHumansHIV-1HIV InfectionsModels, MolecularReceptors, KIR3DL1PeptidesBinding SitesCD8-Positive T-LymphocytesPolymorphism, GeneticProtein Stability

Stichwörter der Autor:innen

CD8(+) T cellsHIVHLAKIRNK cellsTCRimmunogenetics

Substanzen

HLA-B AntigensReceptors, Antigen, T-CellReceptors, KIR3DL1PeptidesKIR3DL1 protein, humanHLA-B*57:01 antigen

Autor:innen und Institutionen

  • Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.
  • Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA; The First Affiliated School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027…
  • Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02142, USA.
  • Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Ins…

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Tano-Menka, R., Singh, N. K., Muzhingi, I., Li, X., Mandanas, M. V., Kaseke, C., Crain, C. R., Zhang, A., Ogunshola, F. J., Vecchiarello, L., Piechocka-Trocha, A., Bashirova, A., Birnbaum, M. E., Carrington, M., Walker, B. D., & Gaiha, G. D. (2024). Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules. Structure. https://doi.org/10.1016/j.str.2024.04.015

Vancouver

Tano-Menka R, Singh NK, Muzhingi I, Li X, Mandanas MV, Kaseke C, et al. Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules. Structure. 2024. doi:10.1016/j.str.2024.04.015

BibTeX
@article{TanoMenka2024,
  author = {Tano-Menka, Rhoda and Singh, Nishant K and Muzhingi, Itai and Li, Xiaolong and Mandanas, Michael V and Kaseke, Clarety and Crain, Charles R and Zhang, Angela and Ogunshola, Funsho J and Vecchiarello, Liza and Piechocka-Trocha, Alicja and Bashirova, Arman and Birnbaum, Michael E and Carrington, Mary and Walker, Bruce D and Gaiha, Gaurav D},
  title = {Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules},
  journal = {Structure},
  year = {2024},
  doi = {10.1016/j.str.2024.04.015}
}
Kostenlos starten →